Cargando…

Immune Enhancement of Skin Carcinogenesis by CD4(+) T Cells

In a transgenic model of multi-stage squamous carcinogenesis induced by human papillomavirus (HPV) oncogenes, infiltrating CD4(+) T cells can be detected in both premalignant and malignant lesions. The lymph nodes that drain sites of epidermal neoplasia contain activated CD4(+) T cells predominantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniel, Dylan, Meyer-Morse, Nicole, Bergsland, Emily K., Dehne, Kerstin, Coussens, Lisa M., Hanahan, Douglas
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193878/
https://www.ncbi.nlm.nih.gov/pubmed/12695493
http://dx.doi.org/10.1084/jem.20021047
Descripción
Sumario:In a transgenic model of multi-stage squamous carcinogenesis induced by human papillomavirus (HPV) oncogenes, infiltrating CD4(+) T cells can be detected in both premalignant and malignant lesions. The lymph nodes that drain sites of epidermal neoplasia contain activated CD4(+) T cells predominantly reactive toward Staphylococcal bacterial antigens. HPV16 mice deficient in CD4(+) T cells were found to have delayed neoplastic progression and a lower incidence of tumors. This delay in carcinogenesis is marked by decreased infiltration of neutrophils, and reduced activity of matrix metalloproteinase-9, an important cofactor for tumor progression in this model. The data reveal an unexpected capability of CD4 T cells, whereby, proinflammatory CD4(+) T cells, apparently responding to bacterial infection of dysplastic skin lesions, can inadvertently enhance neoplastic progression to invasive cancer.